© 2019 The Sonder Group

Having just returned from the ASHG (American Society for Human Genetics) meeting in San Francisco, it occurred to me to share three top things to consider when networking at meetings. Whether you are trying to do a business development deal, start a scientific collaboration or network for your next job, here are three things to consider;

1. Plan ahead: We are all busy in our daily lives. It is easy to jump on that plane and figure out what you are doing at the conference while you pursue the schedule over coffee on the first day. Inste...

There’s never a better way to kick off a new year than to join the mobs descending on San Francisco for the annual JP Morgan Healthcare Conference — especially after a year that saw its ups and downs. The place was teeming with investors trying hard not to think of the European financial situation; with companies in search of funding; with industry leaders, insiders and observers of all stripes. And every one of them networking furiously. It’s biotech’s version of mass speed dating. At JP Morgan, if you don’t have an invite, you can s...

There’s an undeniable excitement when a new technology really hits its stride, and that excitement pretty much sparkled all over John Boyce’s third Consumer Genetics Show. There was the A-list of academic and corporate speakers. There was the participation of the full range of stakeholders, from regulatory experts, genomics CEOs, and academic leaders to cancer patients (the affordable $20 entrance fee helped). There was the fact that John is one of the most well-networked people in our business, and he’s got a Midas touch when it come...

Once again, the Massachusetts Technology Transfer Center scored a direct hit with their Early-Stage Life Sciences Conference VII. Partnering with the Merck Research Labs, they lined up an impressive array of new companies loaded with pedigreed, serial entrepreneurs from Harvard, MIT, Genzyme, Hologics, and other leading academic centers and corporations. Each of the sixteen companies had ten minutes to pitch their newco to investors and the biotech community – which gave the proceedings a kind of mini- JP Morgan Life Sciences Conferen...

Please reload

Categories
Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon